Global Sartan-series Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Sartan-series drugs are one of the commonly used clinical antihypertensive drugs, ending with 'sartan', such as losartan, valsartan, telmisartan, also known as angiotensin II receptor antagonists or Angiotensin receptor blocker (ARBs). They include irbesartan, valsartan, losartan and candesartan. If the name of a medicine ends in ‘sartan’, it is an ARB.
The global Sartan-series Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Sartan-series Drugs Industry Forecast” looks at past sales and reviews total world Sartan-series Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Sartan-series Drugs sales for 2023 through 2029. With Sartan-series Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sartan-series Drugs industry.
This Insight Report provides a comprehensive analysis of the global Sartan-series Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sartan-series Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sartan-series Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sartan-series Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sartan-series Drugs.
United States market for Sartan-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Sartan-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Sartan-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Sartan-series Drugs players cover Novartis, Merck & Co, Sanofi, Pfizer, Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Sartan-series Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sartan-series drugs are one of the commonly used clinical antihypertensive drugs, ending with 'sartan', such as losartan, valsartan, telmisartan, also known as angiotensin II receptor antagonists or Angiotensin receptor blocker (ARBs). They include irbesartan, valsartan, losartan and candesartan. If the name of a medicine ends in ‘sartan’, it is an ARB.
The global Sartan-series Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Sartan-series Drugs Industry Forecast” looks at past sales and reviews total world Sartan-series Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Sartan-series Drugs sales for 2023 through 2029. With Sartan-series Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sartan-series Drugs industry.
This Insight Report provides a comprehensive analysis of the global Sartan-series Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sartan-series Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sartan-series Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sartan-series Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sartan-series Drugs.
United States market for Sartan-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Sartan-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Sartan-series Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Sartan-series Drugs players cover Novartis, Merck & Co, Sanofi, Pfizer, Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Sartan-series Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Losartan
- Valsartan
- Irbesartan
- Telmisartan
- Olmesartan
- Candesartan
- Sacubitril/valsartan
- Others
- Hospital Pharmaty
- Retail Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Losartan
- Valsartan
- Irbesartan
- Telmisartan
- Olmesartan
- Candesartan
- Sacubitril/valsartan
- Others
- Hospital Pharmaty
- Retail Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Merck & Co
- Sanofi
- Pfizer
- Bayer
- AstraZeneca
- Daiichi Sankyo
- Takeda
- Bristol-Myers Squibb Company
- Boehringer Ingelheim
- Abbott
- Teva Pharmaceutical
- Shenzhen Salubris Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sartan-series Drugs Market Size 2019-2030
2.1.2 Sartan-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Sartan-series Drugs by Country/Region, 2019, 2023 & 2030
2.2 Sartan-series Drugs Segment by Type
2.2.1 Losartan
2.2.2 Valsartan
2.2.3 Irbesartan
2.2.4 Telmisartan
2.2.5 Olmesartan
2.2.6 Candesartan
2.2.7 Sacubitril/valsartan
2.2.8 Others
2.3 Sartan-series Drugs Market Size by Type
2.3.1 Sartan-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Sartan-series Drugs Market Size Market Share by Type (2019-2024)
2.4 Sartan-series Drugs Segment by Application
2.4.1 Hospital Pharmaty
2.4.2 Retail Pharmacy
2.5 Sartan-series Drugs Market Size by Application
2.5.1 Sartan-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Sartan-series Drugs Market Size Market Share by Application (2019-2024)
3 SARTAN-SERIES DRUGS MARKET SIZE BY PLAYER
3.1 Sartan-series Drugs Market Size Market Share by Player
3.1.1 Global Sartan-series Drugs Revenue by Player (2019-2024)
3.1.2 Global Sartan-series Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Sartan-series Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SARTAN-SERIES DRUGS BY REGION
4.1 Sartan-series Drugs Market Size by Region (2019-2024)
4.2 Global Sartan-series Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Sartan-series Drugs Market Size Growth (2019-2024)
4.4 APAC Sartan-series Drugs Market Size Growth (2019-2024)
4.5 Europe Sartan-series Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Sartan-series Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Sartan-series Drugs Market Size by Country (2019-2024)
5.2 Americas Sartan-series Drugs Market Size by Type (2019-2024)
5.3 Americas Sartan-series Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sartan-series Drugs Market Size by Region (2019-2024)
6.2 APAC Sartan-series Drugs Market Size by Type (2019-2024)
6.3 APAC Sartan-series Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sartan-series Drugs Market Size by Country (2019-2024)
7.2 Europe Sartan-series Drugs Market Size by Type (2019-2024)
7.3 Europe Sartan-series Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sartan-series Drugs by Region (2019-2024)
8.2 Middle East & Africa Sartan-series Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Sartan-series Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SARTAN-SERIES DRUGS MARKET FORECAST
10.1 Global Sartan-series Drugs Forecast by Region (2025-2030)
10.1.1 Global Sartan-series Drugs Forecast by Region (2025-2030)
10.1.2 Americas Sartan-series Drugs Forecast
10.1.3 APAC Sartan-series Drugs Forecast
10.1.4 Europe Sartan-series Drugs Forecast
10.1.5 Middle East & Africa Sartan-series Drugs Forecast
10.2 Americas Sartan-series Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Sartan-series Drugs Forecast
10.2.2 Canada Market Sartan-series Drugs Forecast
10.2.3 Mexico Market Sartan-series Drugs Forecast
10.2.4 Brazil Market Sartan-series Drugs Forecast
10.3 APAC Sartan-series Drugs Forecast by Region (2025-2030)
10.3.1 China Sartan-series Drugs Market Forecast
10.3.2 Japan Market Sartan-series Drugs Forecast
10.3.3 Korea Market Sartan-series Drugs Forecast
10.3.4 Southeast Asia Market Sartan-series Drugs Forecast
10.3.5 India Market Sartan-series Drugs Forecast
10.3.6 Australia Market Sartan-series Drugs Forecast
10.4 Europe Sartan-series Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Sartan-series Drugs Forecast
10.4.2 France Market Sartan-series Drugs Forecast
10.4.3 UK Market Sartan-series Drugs Forecast
10.4.4 Italy Market Sartan-series Drugs Forecast
10.4.5 Russia Market Sartan-series Drugs Forecast
10.5 Middle East & Africa Sartan-series Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Sartan-series Drugs Forecast
10.5.2 South Africa Market Sartan-series Drugs Forecast
10.5.3 Israel Market Sartan-series Drugs Forecast
10.5.4 Turkey Market Sartan-series Drugs Forecast
10.6 Global Sartan-series Drugs Forecast by Type (2025-2030)
10.7 Global Sartan-series Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Sartan-series Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Sartan-series Drugs Product Offered
11.1.3 Novartis Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Sartan-series Drugs Product Offered
11.2.3 Merck & Co Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Sartan-series Drugs Product Offered
11.3.3 Sanofi Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Sartan-series Drugs Product Offered
11.4.3 Pfizer Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Sartan-series Drugs Product Offered
11.5.3 Bayer Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Sartan-series Drugs Product Offered
11.6.3 AstraZeneca Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Information
11.7.2 Daiichi Sankyo Sartan-series Drugs Product Offered
11.7.3 Daiichi Sankyo Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Daiichi Sankyo Main Business Overview
11.7.5 Daiichi Sankyo Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Sartan-series Drugs Product Offered
11.8.3 Takeda Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Information
11.9.2 Bristol-Myers Squibb Company Sartan-series Drugs Product Offered
11.9.3 Bristol-Myers Squibb Company Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bristol-Myers Squibb Company Main Business Overview
11.9.5 Bristol-Myers Squibb Company Latest Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Information
11.10.2 Boehringer Ingelheim Sartan-series Drugs Product Offered
11.10.3 Boehringer Ingelheim Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Boehringer Ingelheim Main Business Overview
11.10.5 Boehringer Ingelheim Latest Developments
11.11 Abbott
11.11.1 Abbott Company Information
11.11.2 Abbott Sartan-series Drugs Product Offered
11.11.3 Abbott Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Abbott Main Business Overview
11.11.5 Abbott Latest Developments
11.12 Teva Pharmaceutical
11.12.1 Teva Pharmaceutical Company Information
11.12.2 Teva Pharmaceutical Sartan-series Drugs Product Offered
11.12.3 Teva Pharmaceutical Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Teva Pharmaceutical Main Business Overview
11.12.5 Teva Pharmaceutical Latest Developments
11.13 Shenzhen Salubris Pharmaceuticals
11.13.1 Shenzhen Salubris Pharmaceuticals Company Information
11.13.2 Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product Offered
11.13.3 Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Shenzhen Salubris Pharmaceuticals Main Business Overview
11.13.5 Shenzhen Salubris Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sartan-series Drugs Market Size 2019-2030
2.1.2 Sartan-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Sartan-series Drugs by Country/Region, 2019, 2023 & 2030
2.2 Sartan-series Drugs Segment by Type
2.2.1 Losartan
2.2.2 Valsartan
2.2.3 Irbesartan
2.2.4 Telmisartan
2.2.5 Olmesartan
2.2.6 Candesartan
2.2.7 Sacubitril/valsartan
2.2.8 Others
2.3 Sartan-series Drugs Market Size by Type
2.3.1 Sartan-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Sartan-series Drugs Market Size Market Share by Type (2019-2024)
2.4 Sartan-series Drugs Segment by Application
2.4.1 Hospital Pharmaty
2.4.2 Retail Pharmacy
2.5 Sartan-series Drugs Market Size by Application
2.5.1 Sartan-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Sartan-series Drugs Market Size Market Share by Application (2019-2024)
3 SARTAN-SERIES DRUGS MARKET SIZE BY PLAYER
3.1 Sartan-series Drugs Market Size Market Share by Player
3.1.1 Global Sartan-series Drugs Revenue by Player (2019-2024)
3.1.2 Global Sartan-series Drugs Revenue Market Share by Player (2019-2024)
3.2 Global Sartan-series Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SARTAN-SERIES DRUGS BY REGION
4.1 Sartan-series Drugs Market Size by Region (2019-2024)
4.2 Global Sartan-series Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Sartan-series Drugs Market Size Growth (2019-2024)
4.4 APAC Sartan-series Drugs Market Size Growth (2019-2024)
4.5 Europe Sartan-series Drugs Market Size Growth (2019-2024)
4.6 Middle East & Africa Sartan-series Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Sartan-series Drugs Market Size by Country (2019-2024)
5.2 Americas Sartan-series Drugs Market Size by Type (2019-2024)
5.3 Americas Sartan-series Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sartan-series Drugs Market Size by Region (2019-2024)
6.2 APAC Sartan-series Drugs Market Size by Type (2019-2024)
6.3 APAC Sartan-series Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sartan-series Drugs Market Size by Country (2019-2024)
7.2 Europe Sartan-series Drugs Market Size by Type (2019-2024)
7.3 Europe Sartan-series Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sartan-series Drugs by Region (2019-2024)
8.2 Middle East & Africa Sartan-series Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Sartan-series Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SARTAN-SERIES DRUGS MARKET FORECAST
10.1 Global Sartan-series Drugs Forecast by Region (2025-2030)
10.1.1 Global Sartan-series Drugs Forecast by Region (2025-2030)
10.1.2 Americas Sartan-series Drugs Forecast
10.1.3 APAC Sartan-series Drugs Forecast
10.1.4 Europe Sartan-series Drugs Forecast
10.1.5 Middle East & Africa Sartan-series Drugs Forecast
10.2 Americas Sartan-series Drugs Forecast by Country (2025-2030)
10.2.1 United States Market Sartan-series Drugs Forecast
10.2.2 Canada Market Sartan-series Drugs Forecast
10.2.3 Mexico Market Sartan-series Drugs Forecast
10.2.4 Brazil Market Sartan-series Drugs Forecast
10.3 APAC Sartan-series Drugs Forecast by Region (2025-2030)
10.3.1 China Sartan-series Drugs Market Forecast
10.3.2 Japan Market Sartan-series Drugs Forecast
10.3.3 Korea Market Sartan-series Drugs Forecast
10.3.4 Southeast Asia Market Sartan-series Drugs Forecast
10.3.5 India Market Sartan-series Drugs Forecast
10.3.6 Australia Market Sartan-series Drugs Forecast
10.4 Europe Sartan-series Drugs Forecast by Country (2025-2030)
10.4.1 Germany Market Sartan-series Drugs Forecast
10.4.2 France Market Sartan-series Drugs Forecast
10.4.3 UK Market Sartan-series Drugs Forecast
10.4.4 Italy Market Sartan-series Drugs Forecast
10.4.5 Russia Market Sartan-series Drugs Forecast
10.5 Middle East & Africa Sartan-series Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Market Sartan-series Drugs Forecast
10.5.2 South Africa Market Sartan-series Drugs Forecast
10.5.3 Israel Market Sartan-series Drugs Forecast
10.5.4 Turkey Market Sartan-series Drugs Forecast
10.6 Global Sartan-series Drugs Forecast by Type (2025-2030)
10.7 Global Sartan-series Drugs Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Sartan-series Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Sartan-series Drugs Product Offered
11.1.3 Novartis Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Sartan-series Drugs Product Offered
11.2.3 Merck & Co Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Sartan-series Drugs Product Offered
11.3.3 Sanofi Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Sartan-series Drugs Product Offered
11.4.3 Pfizer Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Sartan-series Drugs Product Offered
11.5.3 Bayer Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Sartan-series Drugs Product Offered
11.6.3 AstraZeneca Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Information
11.7.2 Daiichi Sankyo Sartan-series Drugs Product Offered
11.7.3 Daiichi Sankyo Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Daiichi Sankyo Main Business Overview
11.7.5 Daiichi Sankyo Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Sartan-series Drugs Product Offered
11.8.3 Takeda Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Information
11.9.2 Bristol-Myers Squibb Company Sartan-series Drugs Product Offered
11.9.3 Bristol-Myers Squibb Company Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bristol-Myers Squibb Company Main Business Overview
11.9.5 Bristol-Myers Squibb Company Latest Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Information
11.10.2 Boehringer Ingelheim Sartan-series Drugs Product Offered
11.10.3 Boehringer Ingelheim Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Boehringer Ingelheim Main Business Overview
11.10.5 Boehringer Ingelheim Latest Developments
11.11 Abbott
11.11.1 Abbott Company Information
11.11.2 Abbott Sartan-series Drugs Product Offered
11.11.3 Abbott Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Abbott Main Business Overview
11.11.5 Abbott Latest Developments
11.12 Teva Pharmaceutical
11.12.1 Teva Pharmaceutical Company Information
11.12.2 Teva Pharmaceutical Sartan-series Drugs Product Offered
11.12.3 Teva Pharmaceutical Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Teva Pharmaceutical Main Business Overview
11.12.5 Teva Pharmaceutical Latest Developments
11.13 Shenzhen Salubris Pharmaceuticals
11.13.1 Shenzhen Salubris Pharmaceuticals Company Information
11.13.2 Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product Offered
11.13.3 Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Shenzhen Salubris Pharmaceuticals Main Business Overview
11.13.5 Shenzhen Salubris Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sartan-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Sartan-series Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Losartan
Table 4. Major Players of Valsartan
Table 5. Major Players of Irbesartan
Table 6. Major Players of Telmisartan
Table 7. Major Players of Olmesartan
Table 8. Major Players of Candesartan
Table 9. Major Players of Sacubitril/valsartan
Table 10. Major Players of Others
Table 11. Sartan-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 13. Global Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Table 14. Sartan-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 15. Global Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 16. Global Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Table 17. Global Sartan-series Drugs Revenue by Player (2019-2024) & ($ millions)
Table 18. Global Sartan-series Drugs Revenue Market Share by Player (2019-2024)
Table 19. Sartan-series Drugs Key Players Head office and Products Offered
Table 20. Sartan-series Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Sartan-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 24. Global Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Table 25. Global Sartan-series Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 26. Global Sartan-series Drugs Revenue Market Share by Country/Region (2019-2024)
Table 27. Americas Sartan-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 28. Americas Sartan-series Drugs Market Size Market Share by Country (2019-2024)
Table 29. Americas Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 30. Americas Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Table 31. Americas Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 32. Americas Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Table 33. APAC Sartan-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 34. APAC Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Table 35. APAC Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 36. APAC Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 37. Europe Sartan-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 38. Europe Sartan-series Drugs Market Size Market Share by Country (2019-2024)
Table 39. Europe Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 40. Europe Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 41. Middle East & Africa Sartan-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 42. Middle East & Africa Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 43. Middle East & Africa Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 44. Key Market Drivers & Growth Opportunities of Sartan-series Drugs
Table 45. Key Market Challenges & Risks of Sartan-series Drugs
Table 46. Key Industry Trends of Sartan-series Drugs
Table 47. Global Sartan-series Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 48. Global Sartan-series Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 49. Global Sartan-series Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 50. Global Sartan-series Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 51. Novartis Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 52. Novartis Sartan-series Drugs Product Offered
Table 53. Novartis Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Merck & Co Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 57. Merck & Co Sartan-series Drugs Product Offered
Table 58. Merck & Co Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Merck & Co Main Business
Table 60. Merck & Co Latest Developments
Table 61. Sanofi Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 62. Sanofi Sartan-series Drugs Product Offered
Table 63. Sanofi Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Sanofi Main Business
Table 65. Sanofi Latest Developments
Table 66. Pfizer Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 67. Pfizer Sartan-series Drugs Product Offered
Table 68. Pfizer Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Bayer Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 72. Bayer Sartan-series Drugs Product Offered
Table 73. Bayer Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Bayer Main Business
Table 75. Bayer Latest Developments
Table 76. AstraZeneca Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 77. AstraZeneca Sartan-series Drugs Product Offered
Table 78. AstraZeneca Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Latest Developments
Table 81. Daiichi Sankyo Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 82. Daiichi Sankyo Sartan-series Drugs Product Offered
Table 83. Daiichi Sankyo Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Daiichi Sankyo Main Business
Table 85. Daiichi Sankyo Latest Developments
Table 86. Takeda Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 87. Takeda Sartan-series Drugs Product Offered
Table 88. Takeda Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Takeda Main Business
Table 90. Takeda Latest Developments
Table 91. Bristol-Myers Squibb Company Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 92. Bristol-Myers Squibb Company Sartan-series Drugs Product Offered
Table 93. Bristol-Myers Squibb Company Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Bristol-Myers Squibb Company Main Business
Table 95. Bristol-Myers Squibb Company Latest Developments
Table 96. Boehringer Ingelheim Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 97. Boehringer Ingelheim Sartan-series Drugs Product Offered
Table 98. Boehringer Ingelheim Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Boehringer Ingelheim Main Business
Table 100. Boehringer Ingelheim Latest Developments
Table 101. Abbott Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 102. Abbott Sartan-series Drugs Product Offered
Table 103. Abbott Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Abbott Main Business
Table 105. Abbott Latest Developments
Table 106. Teva Pharmaceutical Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 107. Teva Pharmaceutical Sartan-series Drugs Product Offered
Table 108. Teva Pharmaceutical Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Teva Pharmaceutical Main Business
Table 110. Teva Pharmaceutical Latest Developments
Table 111. Shenzhen Salubris Pharmaceuticals Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 112. Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product Offered
Table 113. Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Shenzhen Salubris Pharmaceuticals Main Business
Table 115. Shenzhen Salubris Pharmaceuticals Latest Developments
Table 1. Sartan-series Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Sartan-series Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Losartan
Table 4. Major Players of Valsartan
Table 5. Major Players of Irbesartan
Table 6. Major Players of Telmisartan
Table 7. Major Players of Olmesartan
Table 8. Major Players of Candesartan
Table 9. Major Players of Sacubitril/valsartan
Table 10. Major Players of Others
Table 11. Sartan-series Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 12. Global Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 13. Global Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Table 14. Sartan-series Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 15. Global Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 16. Global Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Table 17. Global Sartan-series Drugs Revenue by Player (2019-2024) & ($ millions)
Table 18. Global Sartan-series Drugs Revenue Market Share by Player (2019-2024)
Table 19. Sartan-series Drugs Key Players Head office and Products Offered
Table 20. Sartan-series Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Sartan-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 24. Global Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Table 25. Global Sartan-series Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 26. Global Sartan-series Drugs Revenue Market Share by Country/Region (2019-2024)
Table 27. Americas Sartan-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 28. Americas Sartan-series Drugs Market Size Market Share by Country (2019-2024)
Table 29. Americas Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 30. Americas Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Table 31. Americas Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 32. Americas Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Table 33. APAC Sartan-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 34. APAC Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Table 35. APAC Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 36. APAC Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 37. Europe Sartan-series Drugs Market Size by Country (2019-2024) & ($ millions)
Table 38. Europe Sartan-series Drugs Market Size Market Share by Country (2019-2024)
Table 39. Europe Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 40. Europe Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 41. Middle East & Africa Sartan-series Drugs Market Size by Region (2019-2024) & ($ millions)
Table 42. Middle East & Africa Sartan-series Drugs Market Size by Type (2019-2024) & ($ millions)
Table 43. Middle East & Africa Sartan-series Drugs Market Size by Application (2019-2024) & ($ millions)
Table 44. Key Market Drivers & Growth Opportunities of Sartan-series Drugs
Table 45. Key Market Challenges & Risks of Sartan-series Drugs
Table 46. Key Industry Trends of Sartan-series Drugs
Table 47. Global Sartan-series Drugs Market Size Forecast by Region (2025-2030) & ($ millions)
Table 48. Global Sartan-series Drugs Market Size Market Share Forecast by Region (2025-2030)
Table 49. Global Sartan-series Drugs Market Size Forecast by Type (2025-2030) & ($ millions)
Table 50. Global Sartan-series Drugs Market Size Forecast by Application (2025-2030) & ($ millions)
Table 51. Novartis Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 52. Novartis Sartan-series Drugs Product Offered
Table 53. Novartis Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Merck & Co Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 57. Merck & Co Sartan-series Drugs Product Offered
Table 58. Merck & Co Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Merck & Co Main Business
Table 60. Merck & Co Latest Developments
Table 61. Sanofi Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 62. Sanofi Sartan-series Drugs Product Offered
Table 63. Sanofi Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Sanofi Main Business
Table 65. Sanofi Latest Developments
Table 66. Pfizer Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 67. Pfizer Sartan-series Drugs Product Offered
Table 68. Pfizer Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Pfizer Main Business
Table 70. Pfizer Latest Developments
Table 71. Bayer Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 72. Bayer Sartan-series Drugs Product Offered
Table 73. Bayer Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Bayer Main Business
Table 75. Bayer Latest Developments
Table 76. AstraZeneca Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 77. AstraZeneca Sartan-series Drugs Product Offered
Table 78. AstraZeneca Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Latest Developments
Table 81. Daiichi Sankyo Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 82. Daiichi Sankyo Sartan-series Drugs Product Offered
Table 83. Daiichi Sankyo Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Daiichi Sankyo Main Business
Table 85. Daiichi Sankyo Latest Developments
Table 86. Takeda Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 87. Takeda Sartan-series Drugs Product Offered
Table 88. Takeda Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Takeda Main Business
Table 90. Takeda Latest Developments
Table 91. Bristol-Myers Squibb Company Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 92. Bristol-Myers Squibb Company Sartan-series Drugs Product Offered
Table 93. Bristol-Myers Squibb Company Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Bristol-Myers Squibb Company Main Business
Table 95. Bristol-Myers Squibb Company Latest Developments
Table 96. Boehringer Ingelheim Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 97. Boehringer Ingelheim Sartan-series Drugs Product Offered
Table 98. Boehringer Ingelheim Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Boehringer Ingelheim Main Business
Table 100. Boehringer Ingelheim Latest Developments
Table 101. Abbott Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 102. Abbott Sartan-series Drugs Product Offered
Table 103. Abbott Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Abbott Main Business
Table 105. Abbott Latest Developments
Table 106. Teva Pharmaceutical Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 107. Teva Pharmaceutical Sartan-series Drugs Product Offered
Table 108. Teva Pharmaceutical Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Teva Pharmaceutical Main Business
Table 110. Teva Pharmaceutical Latest Developments
Table 111. Shenzhen Salubris Pharmaceuticals Details, Company Type, Sartan-series Drugs Area Served and Its Competitors
Table 112. Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product Offered
Table 113. Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Shenzhen Salubris Pharmaceuticals Main Business
Table 115. Shenzhen Salubris Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Sartan-series Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sartan-series Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Sartan-series Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Sartan-series Drugs Sales Market Share by Country/Region (2023)
Figure 8. Sartan-series Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Sartan-series Drugs Market Size Market Share by Type in 2023
Figure 10. Sartan-series Drugs in Hospital Pharmaty
Figure 11. Global Sartan-series Drugs Market: Hospital Pharmaty (2019-2024) & ($ millions)
Figure 12. Sartan-series Drugs in Retail Pharmacy
Figure 13. Global Sartan-series Drugs Market: Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Global Sartan-series Drugs Market Size Market Share by Application in 2023
Figure 15. Global Sartan-series Drugs Revenue Market Share by Player in 2023
Figure 16. Global Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Figure 17. Americas Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 18. APAC Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 19. Europe Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 21. Americas Sartan-series Drugs Value Market Share by Country in 2023
Figure 22. United States Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Sartan-series Drugs Market Size Market Share by Region in 2023
Figure 27. APAC Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Figure 28. APAC Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Figure 29. China Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. India Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Sartan-series Drugs Market Size Market Share by Country in 2023
Figure 36. Europe Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Figure 37. Europe Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Figure 38. Germany Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. France Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 52. APAC Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 53. Europe Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 55. United States Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 56. Canada Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 57. Mexico Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 58. Brazil Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 59. China Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 60. Japan Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 61. Korea Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 63. India Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 64. Australia Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 65. Germany Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 66. France Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 67. UK Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 68. Italy Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 69. Russia Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 70. Egypt Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 71. South Africa Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 72. Israel Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 73. Turkey Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 75. Global Sartan-series Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Sartan-series Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Sartan-series Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sartan-series Drugs Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Sartan-series Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Sartan-series Drugs Sales Market Share by Country/Region (2023)
Figure 8. Sartan-series Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Sartan-series Drugs Market Size Market Share by Type in 2023
Figure 10. Sartan-series Drugs in Hospital Pharmaty
Figure 11. Global Sartan-series Drugs Market: Hospital Pharmaty (2019-2024) & ($ millions)
Figure 12. Sartan-series Drugs in Retail Pharmacy
Figure 13. Global Sartan-series Drugs Market: Retail Pharmacy (2019-2024) & ($ millions)
Figure 14. Global Sartan-series Drugs Market Size Market Share by Application in 2023
Figure 15. Global Sartan-series Drugs Revenue Market Share by Player in 2023
Figure 16. Global Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Figure 17. Americas Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 18. APAC Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 19. Europe Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 20. Middle East & Africa Sartan-series Drugs Market Size 2019-2024 ($ millions)
Figure 21. Americas Sartan-series Drugs Value Market Share by Country in 2023
Figure 22. United States Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 23. Canada Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 24. Mexico Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 25. Brazil Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 26. APAC Sartan-series Drugs Market Size Market Share by Region in 2023
Figure 27. APAC Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Figure 28. APAC Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Figure 29. China Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 30. Japan Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 31. South Korea Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 32. Southeast Asia Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 33. India Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 34. Australia Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 35. Europe Sartan-series Drugs Market Size Market Share by Country in 2023
Figure 36. Europe Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Figure 37. Europe Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Figure 38. Germany Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 39. France Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 40. UK Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 41. Italy Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 42. Russia Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 43. Middle East & Africa Sartan-series Drugs Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Sartan-series Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Sartan-series Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 47. South Africa Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 48. Israel Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 49. Turkey Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 50. GCC Countries Sartan-series Drugs Market Size Growth 2019-2024 ($ millions)
Figure 51. Americas Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 52. APAC Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 53. Europe Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 54. Middle East & Africa Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 55. United States Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 56. Canada Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 57. Mexico Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 58. Brazil Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 59. China Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 60. Japan Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 61. Korea Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 62. Southeast Asia Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 63. India Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 64. Australia Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 65. Germany Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 66. France Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 67. UK Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 68. Italy Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 69. Russia Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 70. Egypt Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 71. South Africa Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 72. Israel Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 73. Turkey Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 74. GCC Countries Sartan-series Drugs Market Size 2025-2030 ($ millions)
Figure 75. Global Sartan-series Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 76. Global Sartan-series Drugs Market Size Market Share Forecast by Application (2025-2030)
